Search Results

Canagliflozin or acarbose versus placebo to ameliorate post‐bariatric hypoglycaemia – The HypoBar I randomized clinical trial protocol.

• Authors : Lobato, Carolina B.; Winding, Clara Tornoe; Bojsen‐Møller, Kirstine N.

Subjects: PREVENTION of surgical complications; CANAGLIFLOZIN; BARIATRIC surgery

• Source: Diabetic Medicine. Jun2024, Vol. 41 Issue 6, p1-8. 8p.

Record details

α-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7–36 amide) and to delay gastric emptying in Type 2 diabetic patients.

• Authors : Hücking, K.; Kostic, Z.; Pox, C.

Subjects: GLUCOSIDASES; ACARBOSE; GLUCAGON

• Source: Diabetic Medicine; Apr2005, Vol. 22 Issue 4, p470-476, 7p

Record details

Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled,double-blind, multicentre study.

• Authors : Riccardi, G.; Giacco, R.; Parillo, M.

Subjects: ACARBOSE; TREATMENT of diabetes; THERAPEUTICS

• Source: Diabetic Medicine; Mar1999, Vol. 16 Issue 3, p228-232, 5p, 2 Charts, 1 Graph

Record details

Low-dose acarbose does not delay digestion of starch but reduces its bioavailability.

• Authors : Wachters-Hagedoorn, R. E.; Priebe, M. G.; Heimweg, J. A. J.

Subjects: ACARBOSE; DIGESTION; STARCH

• Source: Diabetic Medicine; Jun2007, Vol. 24 Issue 6, p600-606, 7p, 1 Diagram, 1 Chart, 1 Graph

Record details

What's new in the journals?

Subjects: *TREATMENT of diabetes; *ACARBOSE; *GLUCOSIDASE inhibitors

• Source: Diabetic Medicine. Jan2005 Supplement 1, Vol. 22, p2-5. 4p.

Record details

Reply to 'Long-term use of acarbose and CV event: confusing finding from mega data bank'.

• Authors : Chang, C.‐H.; Chang, Y.‐C.; Lin, J.‐W.

Subjects: HEART disease risk factors; TYPE 2 diabetes treatment; METFORMIN

• Source: Diabetic Medicine; Dec2016, Vol. 33 Issue 12, p1750-1751, 2p

Record details

The Effect of the Timing and the Administration of Acarbose on Postprandial Hyperglycaemia.

• Authors : Rosak, C.; Nitzsche, G.; König, P.

• Source: Diabetic Medicine; Nov1995, Vol. 12 Issue 11, p979-984, 6p

Record details

Acarbose treatment does not change the habitual diet of patients with Type 2 diabetes mellitus.

• Authors : Lindström, J.; Tuomilehto, J.; Spengler, M.

Subjects: ACARBOSE; PEOPLE with diabetes; TYPE 2 diabetes treatment

• Source: Diabetic Medicine; Jan2000, Vol. 17 Issue 1, p20-25, 6p, 4 Charts, 1 Graph

Record details

Long-term use of acarbose and CV Event: confusing finding from mega data bank.

• Authors : Wu, C.‐H.; Shen, C.‐J.; Wu, K.‐L.

Subjects: TYPE 2 diabetes treatment; TREATMENT effectiveness; ACARBOSE

• Source: Diabetic Medicine; Dec2016, Vol. 33 Issue 12, p1749-1750, 2p

Record details

Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial.

• Authors : Pan, C.; Yang, W.; Barona, J. P.

Subjects: TYPE 2 diabetes; ENDOCRINE diseases; BLOOD plasma

• Source: Diabetic Medicine; Apr2008, Vol. 25 Issue 4, p435-441, 7p, 1 Diagram, 2 Charts, 1 Graph

Record details